Savvy Updates 8/19/24:  Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Tandem warns iPhone app still draining insulin pump batteries by Elise Reuter for MedTechDive.com, 15 August 2024. Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected...
Savvy Updates, 8/12/24: Medtronic Simplera CGM Approved, Medtronic/Abbott CGM Integration, Diabeloop Study on Disparities in Insulin Needs Between Sexes, Accu-Chek SmartGuide Approved in Europe, Most Downloaded Apps to Manage T1D

Savvy Updates, 8/12/24: Medtronic Simplera CGM Approved, Medtronic/Abbott CGM Integration, Diabeloop Study on Disparities in Insulin Needs Between Sexes, Accu-Chek SmartGuide Approved in Europe, Most Downloaded Apps to Manage T1D

FDA approves next-generation CGM with two-step insertion process by Jill Rollet for Healio.com/endocrinology, 7 August 2024. FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes.  The Simplera CGM (Medtronic) is a CGM...
Savvy Updates 7/29/24:  Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Abbott Issues Warning for Certain FreeStyle Libre 3 Sensors by Paul Heltzel for diaTribe.org, 25 July 2024. Some FreeStyle Libre 3 continuous glucose monitoring sensors could display false high readings and should be immediately discontinued, urged the manufacturer....
Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Dexcom G7 & Geofencing: Travel Alert If you are a Dexcom G7 user or using MDI with connection to phone app, PLEASE READ: you are planning travel shortly away from your home country, and you use open-source DIY app or MDI or Mobi or will use O5 with G7 Dexcom G7 is...
Savvy Updates 7/15/24:  Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Skip to content